避孕药使用与炎症性肠病风险:巢式病例对照研究
孕激素单药口服与溃疡性结肠炎有轻度关联,与克罗恩病无关;肠外避孕与IBD无关联。
要点
- 复方口服避孕药与克罗恩病(OR 1.60)和溃疡性结肠炎(OR 1.30)风险升高相关。
- 复方口服避孕药每增加一年随访中一个月的暴露,克罗恩病风险增加6.4%,溃疡性结肠炎增加3.3%。
- 孕激素单药口服与溃疡性结肠炎轻度相关(OR 1.35),与克罗恩病无关;肠外避孕无关联。
核心结论
- 复方口服避孕药暴露时间越长,IBD风险越高,支持雌激素成分可能驱动IBD发病的假说。
主要发现
- 复方口服避孕药与克罗恩病风险OR 1.60(95%CI 1.41-1.82)和溃疡性结肠炎风险OR 1.30(95%CI 1.15-1.45)相关。
- 复方口服避孕药每增加一年随访中一个月的暴露,克罗恩病风险增加6.4%(95%CI 5.1%-7.7%),溃疡性结肠炎增加3.3%(95%CI 2.1%-4.4%)。
- 孕激素单药口服与克罗恩病风险无关联(OR 1.09,95%CI 0.84-1.40),与溃疡性结肠炎有轻度关联(OR 1.35,95%CI 1.12-1.64)。
- 肠外避孕与克罗恩病(OR 1.15,95%CI 0.99-1.47)和溃疡性结肠炎(OR 1.17,95%CI 0.98-1.39)无关联。
临床怎么用
- 对有IBD风险或家族史的育龄女性,处方复方口服避孕药时应考虑其与IBD风险的关联。
- 孕激素单药口服与克罗恩病无关,但需注意其与溃疡性结肠炎的轻度关联。
- 肠外避孕未显示与IBD风险增加相关,可作为需避孕的IBD风险女性的可选方案之一。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: How contraceptive formulation, dose, duration of therapy and mode of delivery affects the risk of inflammatory bowel disease (IBD) is poorly described. AIM: To examine associations between types of hormonal contraception and development of IBD. METHODS: This was a nested case-control study using IQVIA Medical Research Data. Women aged 15-49 years with a new diagnosis of IBD were matched with up to six controls by age, practice and year. Odds ratios (OR) and 95% confidence intervals (95% CI) for incident IBD and use of contraception were calculated. RESULTS: 4932 incident cases of IBD were matched to 29 340 controls. Use of combined oral contraceptive pills (COCPs) was associated with the development of Crohn's disease and ulcerative colitis (OR 1.60 [1.41-1.82] and 1.30 [1.15-1.45], respectively). Each additional month of COCP exposure per year of follow-up increased risk of Crohn's disease by 6.4% (5.1%-7.7%) and ulcerative colitis by 3.3% (2.1%-4.4%). Progestogen-only pills had no effect on Crohn's disease risk (OR 1.09 [0.84-1.40]) but there was a modest association with ulcerative colitis (OR 1.35 [1.12-1.64]). Parenteral contraception was not associated with the development of Crohn's disease or ulcerative colitis (OR 1.15 [0.99-1.47] and 1.17 [0.98-1.39], respectively). CONCLUSIONS: We observed an increase in the risk of IBD with increasing duration of exposure to COCPs. Progestogen-only pills were not associated with Crohn's disease but there was a modest association with ulcerative colitis. There was no association between parenteral progestogen-only contraception and IBD. These findings are broadly consistent with a hypothesis that the oestrogen component of contraception may drive IBD pathogenesis.
引用
- Pasvol TJ, Bloom S, Segal AW, et al. Use of contraceptives and risk of inflammatory bowel disease: a nested case-control study. Aliment Pharmacol Ther. 2021. PMID: 34662440. doi:10.1111/apt.16647
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。